Slices were perfused with ACSF, which was heated to 35–37°C, equilibrated with 95% O2/5% CO2 and contained (in mM): 126 NaCl, 26 NaHCO3, 3 KCl, 1.25
NaH2PO4, 1.6 CaCl2, 1.5 MgSO4, 10 glucose, 0.05 D-(–)-2-amino-5-phosphonopentanoic acid (APV), 0.02 6,7-dinitroquinoxaline-2,3-dione (DNQX) and 0.002 (2S)-3-{[(1S)-1-(3,4-dichlorophenyl)ethyl]amino-2-hydroxypropyl)(phenylmethyl)phosphinic acid (CGP 55845). APV, DNQX and CGP55845 were used to block NMDA, AMPA/kainate and GABAB receptors, respectively, so that GABAA receptor-mediated currents could be studied in relative isolation (Bevan et al., 2002 (link); Hallworth and Bevan, 2005 (link)). Miniature inhibitory postsynaptic currents (mIPSCs) were recorded in the additional presence of 0.5 µM tetrodotoxin. In some cases sulpiride (2 µM) was added to block D2 dopamine receptors. Drugs were purchased from Abcam except for sulpiride, which was obtained from Tocris.
Somatic patch clamp recordings were obtained under visual guidance (Axioskop FS2, Zeiss) using computer-controlled manipulators (Luigs & Neumann) and a Multiclamp 700B amplifier and digidata 1440A digitizer controlled by PClamp 10 (Molecular Devices). Pipettes contained (in mM): 135 CsCl, 3.6 NaCl, 1 MgCl2, 10 HEPES, 10 QX-314, 0.1 Na4EGTA, 0.4 Na3GTP and 2 Mg1.5ATP (pH 7.2, 290 mOsm) or 130 Kgluconate, 3.6 Nagluconate, 1 MgCl2, 10 HEPES, 10 QX-314, TEA-Cl 5, 0.1 Na4EGTA, 0.4 Na3GTP and 2 Mg1.5ATP (pH 7.2, 290 mOsm) for the recording of GABAA receptor-mediated mIPSCs and evoked currents, respectively. mIPSCs were recorded at −60 mV. Evoked IPSCs and isoguvacine-evoked current were recorded at −50 mV. Weighted decay kinetics ofmIPSCs were calculated from τ decay = (A1*τ1 + A2*τ2)/(A1 + A2) where A and τ refer to the amplitude and decay constants, respectively, of biexponential fits of mIPSCs. Data were analyzed with Clampfit 10 (Molecular Devices), Igor Pro 6 (Wavemetrics) and Origin 8 (OriginLab).
NaH2PO4, 1.6 CaCl2, 1.5 MgSO4, 10 glucose, 0.05 D-(–)-2-amino-5-phosphonopentanoic acid (APV), 0.02 6,7-dinitroquinoxaline-2,3-dione (DNQX) and 0.002 (2S)-3-{[(1S)-1-(3,4-dichlorophenyl)ethyl]amino-2-hydroxypropyl)(phenylmethyl)phosphinic acid (CGP 55845). APV, DNQX and CGP55845 were used to block NMDA, AMPA/kainate and GABAB receptors, respectively, so that GABAA receptor-mediated currents could be studied in relative isolation (Bevan et al., 2002 (link); Hallworth and Bevan, 2005 (link)). Miniature inhibitory postsynaptic currents (mIPSCs) were recorded in the additional presence of 0.5 µM tetrodotoxin. In some cases sulpiride (2 µM) was added to block D2 dopamine receptors. Drugs were purchased from Abcam except for sulpiride, which was obtained from Tocris.
Somatic patch clamp recordings were obtained under visual guidance (Axioskop FS2, Zeiss) using computer-controlled manipulators (Luigs & Neumann) and a Multiclamp 700B amplifier and digidata 1440A digitizer controlled by PClamp 10 (Molecular Devices). Pipettes contained (in mM): 135 CsCl, 3.6 NaCl, 1 MgCl2, 10 HEPES, 10 QX-314, 0.1 Na4EGTA, 0.4 Na3GTP and 2 Mg1.5ATP (pH 7.2, 290 mOsm) or 130 Kgluconate, 3.6 Nagluconate, 1 MgCl2, 10 HEPES, 10 QX-314, TEA-Cl 5, 0.1 Na4EGTA, 0.4 Na3GTP and 2 Mg1.5ATP (pH 7.2, 290 mOsm) for the recording of GABAA receptor-mediated mIPSCs and evoked currents, respectively. mIPSCs were recorded at −60 mV. Evoked IPSCs and isoguvacine-evoked current were recorded at −50 mV. Weighted decay kinetics ofmIPSCs were calculated from τ decay = (A1*τ1 + A2*τ2)/(A1 + A2) where A and τ refer to the amplitude and decay constants, respectively, of biexponential fits of mIPSCs. Data were analyzed with Clampfit 10 (Molecular Devices), Igor Pro 6 (Wavemetrics) and Origin 8 (OriginLab).